A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.

Fluoroquinolone prophylaxis in patients with profound neutropenia may be useful for preventing gram-negative bacterial infection, but it is ineffective against gram-positive bacterial infections in the bloodstream, particularly those caused by streptococci and coagulase-negative staphylococci, which...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Kern, W V, Hay, B, Kern, P, Marre, R, Arnold, R
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1994
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284481/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8203838/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.3.465
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!